|
FY2025
6 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from Operating Activities: | |
| Net Income | |
| Adjustments to reconcile net income to net cash used in operating activities: | |
| Payment of expenses through promissory note – related party | |
| Interest income on trust account | |
| Changes in operating assets and liabilities: | |
| Prepaid expenses | |
| Other Payables | |
| Accrued Expenses | |
| Net cash used in operating activities | |
| Cash flows from investing activities: | |
| Investment of cash in Trust Account | |
| Net cash used in investing activities | |
| Cash flows from financing activities: | |
| Proceeds from issuance of ordinary shares to Sponsor | |
| Proceeds from sale of public units, net of underwriting discount paid | |
| Proceeds from sale of private placement units | |
| Repayment of promissory note | |
| Payment of offering costs | |
| Net cash provided by financing activities | |
| Net change in cash | |
| Cash at the end of the period | |
| Supplemental disclosure of non-cash financing activities: | |
| Deferred underwriting fee payable | |
| Accretion of ordinary shares subject to redemption for interest income on trust account |
Loading...
